Effectiveness and Safety of Omidenepag Isopropyl 0.002% Ophthalmic Solution in Treatment-Naive Patients With Primary Open Angle Glaucoma: A Prospective Multicenter Phase IV Study
Omidenepag isopropyl 0.002% ophthalmic solution is suitable for first-line use at first diagnosis of POAG, including in patients with NTG.
Authors
- Hyoung Won Bae (ORCID: https://orcid.org/0000-0002-8421-5636)
- Ki Ho Park (ORCID: https://orcid.org/0000-0002-8137-8843)
- Eun Ji Lee
- Jong Jin Jung (ORCID: https://orcid.org/0009-0003-5696-8539)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Seoul National University Hospital (KR)
- Seoul National University Bundang Hospital (KR)
- Kim's Eye Hospital (KR)
Publication Details
- Journal
- Journal of Glaucoma
- Published
- 2025-06-16
- DOI
- https://doi.org/10.1097/ijg.0000000000002605
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00